146 related articles for article (PubMed ID: 1870127)
1. Three-dimensional structure of the complexes between bovine chymotrypsinogen A and two recombinant variants of human pancreatic secretory trypsin inhibitor (Kazal-type).
Hecht HJ; Szardenings M; Collins J; Schomburg D
J Mol Biol; 1991 Aug; 220(3):711-22. PubMed ID: 1870127
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structure of a recombinant variant of human pancreatic secretory trypsin inhibitor (Kazal type).
Hecht HJ; Szardenings M; Collins J; Schomburg D
J Mol Biol; 1992 Jun; 225(4):1095-103. PubMed ID: 1613792
[TBL] [Abstract][Full Text] [Related]
3. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
[TBL] [Abstract][Full Text] [Related]
4. Binding of bovine basic pancreatic trypsin inhibitor (Kunitz) as well as bovine and porcine pancreatic secretory trypsin inhibitor (Kazal) to human cathepsin G: a kinetic and thermodynamic study.
Fioretti E; Angeletti M; Coletta M; Ascenzi P; Bolognesi M; Menegatti E; Rizzi M; Ascoli F
J Enzyme Inhib; 1993; 7(1):57-64. PubMed ID: 7510795
[TBL] [Abstract][Full Text] [Related]
5. Binding of the bovine and porcine pancreatic secretory trypsin inhibitor (Kazal) to human leukocyte elastase: a thermodynamic study.
Ascenzi P; Amiconi G; Bolognesi M; Onesti S; Petruzzelli R; Menegatti E
J Enzyme Inhib; 1991; 5(3):207-13. PubMed ID: 1669448
[TBL] [Abstract][Full Text] [Related]
6. Highly effective protease inhibitors from variants of human pancreatic secretory trypsin inhibitor (hPSTI): an assessment of 3-D structure-based protein design.
Szardenings M; Vasel B; Hecht HJ; Collins J; Schomburg D
Protein Eng; 1995 Jan; 8(1):45-52. PubMed ID: 7770451
[TBL] [Abstract][Full Text] [Related]
7. Production of specific monoclonal antibodies against the active sites of human pancreatic secretory trypsin inhibitor variants by in vitro immunization with synthetic peptides.
Böldicke T; Kindt S; Maywald F; Fitzlaff G; Böcher M; Frank R; Collins J
Eur J Biochem; 1988 Aug; 175(2):259-64. PubMed ID: 3402453
[TBL] [Abstract][Full Text] [Related]
8. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
10. The isolation and partial characterization of trypsinogen, pancreatic secretory trypsin inhibitor and multiple forms of chymotrypsinogen and trypsin from the pancreas of the ostrich (Struthio camelus).
Smith N; Naudé RJ; Oelofsen W; Lazure C; Patthy A
Int J Biochem; 1992 Jun; 24(6):877-85. PubMed ID: 1612178
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of delta-chymotrypsin bound to a peptidyl chloromethyl ketone inhibitor.
Mac Sweeney A; Birrane G; Walsh MA; O'Connell T; Malthouse JP; Higgins TM
Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):280-6. PubMed ID: 10713514
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of ostrich pancreatic secretory trypsin inhibitor.
Zhao M; Naudé RJ; Muramoto K; Oelofsen W
Int J Pept Protein Res; 1996 Aug; 48(2):174-81. PubMed ID: 8872536
[TBL] [Abstract][Full Text] [Related]
13. The three-dimensional structure of the native ternary complex of bovine pancreatic procarboxypeptidase A with proproteinase E and chymotrypsinogen C.
Gomis-Rüth FX; Gómez M; Bode W; Huber R; Avilés FX
EMBO J; 1995 Sep; 14(18):4387-94. PubMed ID: 7556081
[TBL] [Abstract][Full Text] [Related]
14. Zymogen activation in serine proteinases. Proton magnetic resonance pH titration studies of the two histidines of bovine chymotrypsinogen A and chymotrypsin Aalpha.
Markley JL; Ibañez IB
Biochemistry; 1978 Oct; 17(22):4627-40. PubMed ID: 31898
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.
Bolognesi M; Gatti G; Menagatti E; Guarneri M; Marquart M; Papamokos E; Huber R
J Mol Biol; 1982 Dec; 162(4):839-68. PubMed ID: 7169635
[No Abstract] [Full Text] [Related]
16. A mutant trypsin-like enzyme from Streptomyces fradiae, created by site-directed mutagenesis, improves affinity chromatography for protein trypsin inhibitors.
Katoh T; Kikuchi N; Nagata K; Yoshida N
Appl Microbiol Biotechnol; 1996 Aug; 46(1):15-21. PubMed ID: 8987530
[TBL] [Abstract][Full Text] [Related]
17. Partially folded bovine pancreatic trypsin inhibitor analogues attain fully native structures when co-crystallized with S195A rat trypsin.
Getun IV; Brown CK; Tulla-Puche J; Ohlendorf D; Woodward C; Barany G
J Mol Biol; 2008 Jan; 375(3):812-23. PubMed ID: 18054043
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
[TBL] [Abstract][Full Text] [Related]
19. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
Kaslik G; Westler WM; Gráf L; Markley JL
Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
[TBL] [Abstract][Full Text] [Related]
20. Isolation and structural characterization of a molecular variant of dog pancreatic secretory trypsin inhibitor.
Conlon JM; Kim CB; Magee DF
Int J Pancreatol; 1991 Jan; 8(1):59-64. PubMed ID: 2033320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
